Public-registry trials using ALLN-177 that Eichor's radar has found — 2 trials. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria | Allena Pharmaceuticals | Enteric Hyperoxaluria | PHASE3 | 63 |
| Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia | Allena Pharmaceuticals | Enteric Hyperoxaluria | PHASE2 | 9 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →